Viewing StudyNCT00079768



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00079768
Status: COMPLETED
Last Update Posted: 2010-06-17
First Post: 2004-03-12

Brief Title: Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Sponsor: National Institute of Neurological Disorders and Stroke NINDS
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Myositis Inclusion Body
Keywords:
Name View
Inclusion Body Myositis View
Inflammation View
Myositis View
Humanized Monoclonal Antibody View
Cytotoxic T Cells View
Endomysial T Cells View
Alemtuzumab View
Monoclonal Antibodies View
IBM View
Anti-CD 52 View